Recurrence-free survival and overall survival were more common in patients with nevus-associated acral melanoma compared with ...
Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Penile Cancer.
Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Colorectal Cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback